Staff Directory


Nik Arsyad Bin Nik Muhamad Affendi

Academic Qualification

  • Membership of Royal College of Physicians of Ireland - Masters Degree (Clinical Specialist), Royal College of Physicians of Ireland
  • M.B., B.Ch., B.A.O. - Bachelor Degree, National University of Ireland

Nik Arsyad Bin Nik Muhamad Affendi (Dr.)

Assistant Professor
IIUM Kuantan Campus

KULLIYYAH OF MEDICINE

nik_arsyad@iium.edu.my
NA


Area of Specialisation


  • Medical And Health ~ Medical And Health Sciences ~ Clinical Medicine ~ Surgery


Professional Membership


  • 2014: Member of Profesional Body / Association: (Member), Royal College of Physicians of Ireland


Teaching Responsibilities


GENERAL MEDICAL SPECIALTY/GENERAL MEDICAL POSTING 2020/2021
GENERAL MEDICINE & GENERAL SURGERY 2020/2021 2019/2020
GENERAL MEDICINE I 2024/2025 2023/2024
GENERAL MEDICINE II & SUBSPECIALTY POSTING II 2024/2025 2023/2024
GENERAL MEDICINE/CCU/HDW/A&EPOSTING 2020/2021 2019/2020
INTERNAL MEDICINE I 2023/2024 2020/2021 2019/2020 2018/2019
INTERNAL MEDICINE II 2023/2024 2020/2021 2019/2020 2018/2019
SPECIALIZED POSTING 2020/2021 2019/2020
SUBSPECIALTY POSTING I 2024/2025 2023/2024
THE ALIMENTARY AND HEPATOBILIARY SYSTEMS 2019/2020


Supervision


Prevalence Of Chronic Kidney Disease In Hepatitis C Patients And Their Outcomes With Direct Acting Antiviral (Daa) Therapy In Hospital Tengku Ampuan Afzan.
Master Completed 2023 Main Supervisor
Idiopathic Megacolon In An Adolescent Girl: A Case Report On A Rare Disease.
Master Completed 2023 Co-supervisor


Publications


Article

2023 Frequency of significant steatosis and compensated advanced chronic liver disease among adults with chronic liver disease. Journal of Gastroenterology and Hepatology, 38 (10) pp. 1818-1822
2023 High accuracy of a simplified, practical algorithm in a differentiating Crohn’s disease from Intestinal Tuberculosis. Digestive disease, 41 (4) pp. 581-588
2023 Long term efficacy and persistence of biologics therapy in Crohn’s disease in multiracial Asian country. Journal of Gastroenterology and Hepatology, 38 (S3) pp. 271-271
2023 Reply - Accelerated dose of ustekinumab for acute severe ulcerative colitis. Journal of Gastrointestinal and Liver Diseases, 32 (3) pp. 412-412
2023 Upadacitinib as rescue therapy in acute severe ulcerative colitis: a Malaysia tertiary center experience. Journal of Gastroenterology and Hepatology, 38 (S3) pp. 263-263
2023 When is POEM truly equivalent to LHM? A comparison of complication rates during the learning curve. Surgical Endoscopy, 37 () pp. 1735-1741
2022 Accelerated ustekinumab dosing as rescue therapy in acute severe ulcerative colitis. Journal of Gastrointestinal and Liver Diseases, 31 (4) pp. 478-479
2022 Changing landscape of liver cirrhosis in multi-racial Asian country: a decade comparison. Hepatology International, 16 (July 2022, issue 1) pp. 332-333
2021 Acquiring new complex endoscopic skills: experience from the development of peroral endoscopic myotomy (POEM) in Malaysia. JGH Open, 5 (7) pp. 729-733
2021 Biologic exposure of short duration results in a marked reduction in cumulative surgical rates in Malaysian patients with inflammatory bowel disease. Journal of Gastroenterology and Hepatology, Vol 36 S2 () pp. 233-233
2021 Classification of chest radiographs using novel anomalous saliency map and deep convolutional neural network. IIUM Engineering Journal, 22 (2) pp. 234-248
2021 Efficacy and safety of per-oral endoscopic myotomy for the treatment of Achalasia Cardia in Malaysia: a single centre study. Journal of Gastroenterology and Hepatology, Vol 36 S2 () pp. 360-360
2018 Retrospective study on upper gastrointestinal endoscopic findings in patients with Dyspepsia without Alarm Features in International Islamic University Malaysia Medical Centre. IIUM Medical Journal Malaysia, 17 Supplementary (1) pp. 84-84
Conference or Workshop Item

2022 Accelerated dose of Ustekinumab as rescue therapy in acute severe ulcerative colitis. In: GUT 2022,
2022 Biologic exposure of short duration results in a marked reduction in cumulative surgical rates in Malaysian patients with inflammatory bowel disease. In: GUT 2022,
2022 Changing landscape of liver cirrhosis in multi-racial Asian country: a decade comparison. In: GUT 2022,
2022 Efficacy and safety of per-oral endoscopic myotomy for the treatment of achalasia cardia in Malaysia: a single centre study. In: GUT 2022,
2022 Efficacy, safety and persistence of Ustekinumab versus Infliximab in bionaive patients with moderate to severe Crohn disease patients: a real world experience. In: GUT 2022,
2022 Frequency of significant fibrosis in various chronic liver diseases: an evaluation with Transient Elastography (TE). In: GUT 2022,
2022 Frequency of significant steatosis in various chronic liver diseases: an evaluation with Transient Elastography (TE). In: GUT 2022,
2022 Impact of early versus late use of biologic therapy on cumulative surgical rates in patients with IBD. In: GUT 2022,
2022 When is poem truly equivalent to LHM? A comparison of complication rates during the learning curve. In: GUT 2022,